Farletuzumab Uses, Dosage, Side Effects and more
Farletuzumab (MORAb-003) is a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.
Trade Name | Farletuzumab |
Generic | Farletuzumab |
Farletuzumab Other Names | Farletuzumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in ovarian cancer.